1-4 of 4
Allison C. Chin
Close
Sort by
Journal Articles

GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients.

Robert J. Tressler, PhD, Allison C. Chin, Ph.D., Eric J. Feldman, M.D., Kanti R. Rai, M.D., Doug Kornbrust, Ph.D., Calvin B. Harley, Ph.D., Melissa A. Kelly Behrs, Laurence Elias, MD
Journal: Blood
Blood (2006) 108 (11): 2595.
https://doi.org/10.1182/blood.V108.11.2595.2595
Published: 2006
Journal Articles

The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models.

Server A. Ertem, BS, Kaida Wu, MD, Vladimir Ponomarev, PhD, Allison C. Chin, PhD, Malcolm A.S. Moore, PhD
Journal: Blood
Blood (2005) 106 (11): 3477.
https://doi.org/10.1182/blood.V106.11.3477.3477
Published: 2005
Journal Articles

GRN163L Inhibits Telomerase Activity in B-CLL Cells.

Claudia Lin, PhD, Rajendra N. Damle, PhD, Nicholas Chiorazzi, PhD, Allison C. Chin, PhD
Journal: Blood
Blood (2005) 106 (11): 5041.
https://doi.org/10.1182/blood.V106.11.5041.5041
Published: 2005
Journal Articles

Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma

Eunice S. Wang, Kaida Wu, Allison C. Chin, Selina Chen-Kiang, Krisztina Pongracz, Sergei Gryaznov, Malcolm A. S. Moore
Journal: Blood
Blood (2004) 103 (1): 258–266.
https://doi.org/10.1182/blood-2003-02-0546
Published: 2004